Structure-Based Design of Novel TLR7/8 Agonist Payloads Enabling an Immunomodulatory Conjugate Approach
- 19 December 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 16 (1) , 80-88
Abstract
Dual activation of the TLR7 and TLR8 pathways leads to the production of type I interferon and proinflammatory cytokines, resulting in efficient antigen presentation by dendritic cells to promote T-cell priming and antitumor immunity. We developed a novel series of TLR7/8 dual agonists with varying ratios of TLR7 and TLR8 activity for use as payloads for an antibody-drug conjugate approach. The agonist-induced production of several cytokines in human whole blood confirmed their functional activity. Structure-activity relationship studies guided by structure-based drug design are described.Keywords
This publication has 23 references indexed in Scilit:
- Discovery and Evaluation of TLR-Targeted Immune AgonistsJournal of Medicinal Chemistry, 2024
- Design and Optimization of Selectivity-Tunable Toll-like Receptor 7/8 Agonists as Novel Antibody–Drug Conjugate PayloadsJournal of Medicinal Chemistry, 2024
- Design and Characterization of Immune-Stimulating Imidazo[4,5-c]quinoline Antibody-Drug ConjugatesMolecular Pharmaceutics, 2022
- Immune Modulating Antibody–Drug Conjugate (IM-ADC) for Cancer ImmunotherapyJournal of Medicinal Chemistry, 2021
- Structure-Based Design of Highly Potent Toll-like Receptor 7/8 Dual Agonists for Cancer ImmunotherapyJournal of Medicinal Chemistry, 2021
- Discovery of GS-9688 (Selgantolimod) as a Potent and Selective Oral Toll-Like Receptor 8 Agonist for the Treatment of Chronic Hepatitis BJournal of Medicinal Chemistry, 2020
- Identification and Optimization of Pyrrolo[3,2-d]pyrimidine Toll-like Receptor 7 (TLR7) Selective Agonists for the Treatment of Hepatitis BJournal of Medicinal Chemistry, 2017
- Identification of High-Potency Human TLR8 and Dual TLR7/TLR8 Agonists in Pyrimidine-2,4-diaminesJournal of Medicinal Chemistry, 2017
- Novel Pyrimidine Toll-like Receptor 7 and 8 Dual Agonists to Treat Hepatitis B VirusJournal of Medicinal Chemistry, 2016
- Incorporation of Phosphonate into Benzonaphthyridine Toll-like Receptor 7 Agonists for Adsorption to Aluminum HydroxideJournal of Medicinal Chemistry, 2016